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Abstract: The risk of emergence and/or re-emergence of arthropod-borne viral (arboviral) infections is
rapidly growing worldwide, particularly in Africa. The burden of arboviral infections and diseases is
not well scrutinized because of the inefficient surveillance systems in endemic countries. Furthermore,
the health systems are fully occupied by the burden of other co-existing febrile illnesses, especially
malaria. In this review we summarize the epidemiology and risk factors associated with the major
human arboviral diseases and highlight the gap in knowledge, research, and control in Sudan.
Published data in English up to March 2019 were reviewed and are discussed to identify the risks and
challenges for the control of arboviruses in the country. In addition, the lack of suitable diagnostic
tools such as viral genome sequencing, and the urgent need for establishing a genomic database
of the circulating viruses and potential sources of entry are discussed. Moreover, the research and
healthcare gaps and global health threats are analyzed, and suggestions for developing strategic
health policy for the prevention and control of arboviruses with focus on building the local diagnostic
and research capacity and establishing an early warning surveillance system for the early detection
and containment of arboviral epidemics are offered.
Keywords: arthropod-borne viruses; arboviruses; mosquito-borne viruses; sandfly-borne viruses;
tick-borne viruses; arboviral diseases; emergence; epidemics; outbreaks; Sudan
1. Introduction
Arthropod-borne viruses (arboviruses) have received much global attention recently due to
the Zika virus epidemic in the Americas. The major human arboviruses belong to the Togaviridae,
Flaviviridae, or Peribunyaviridae families [1,2]. These viruses cause serious diseases including dengue
fever, yellow fever, Rift Valley fever, chikungunya, and various arboviral encephalitides. The risk of
arboviral diseases is on the increase and their geographical distribution has expanded [2]. Nevertheless,
little is known about the epidemiology, distribution, and dynamics of arboviruses in Africa [1].
Due to limitations in the capacity of the health systems, particularly at the level of diagnosis of
infectious diseases, many cases of arboviral diseases are misdiagnosed as malaria or any other similar
febrile illness. This, in turn, not only leads to an overestimation of malaria episodes, but also to an
underestimation of arboviral diseases and their socio-economic impacts [3–6].
Viruses 2020, 12, 81; doi:10.3390/v12010081 www.mdpi.com/journal/viruses
Viruses 2020, 12, 81 2 of 16
Several risk factors contribute to the emergence and re-emergence of arboviral diseases. These
include climate change, international travel and trade, increased contact of humans and wild or
domesticated animals, an explosion of the human population, and unplanned urbanization [7–11].
The limited evidence and published data about the risk of arboviruses in Africa restrains the ability of
health systems to develop strategic interventions to control arboviral diseases [4]. Most arboviruses
are zoonotic with frequent spillover and spillback between human and animal populations [2,12].
Interestingly, Sudan is located at a crossroad of international human travel routes, animal exportation
and transportation, and seasonal bird migration routes, which predisposes the Sudanese population to
arbovirus contact [2,13,14]. Considering these factors, understanding the epidemiology of arboviruses
in Sudan is of global concern. Therefore, in this review, we aim to shed light on the risk of arboviruses
in Sudan and highlight the main gaps in knowledge, research, and control of the major human and
veterinary arboviral diseases as well as the main challenges to develop a strategic plan for control.
2. Epidemiology of the Major Arboviral Diseases in Sudan
2.1. Mosquito-Borne Viral Diseases
2.1.1. Yellow Fever Virus
Yellow fever virus (YFV; Flaviviridae) is endemic in Sudan and infections occur throughout the
country (Figure 1). Early studies suggested that yellow fever (YF) has been endemic in the middle
and western regions of the country since the 1800s [15]. The world’s worst recorded outbreak of YF,
with more than 40,000 cases and 1500 deaths, was reported from 1940 to 1941. YFV was detected
in humans, non-human primates, wild and domestic animals in 1941, 1952, and 1953 [15–26]. Soon
thereafter, a second epidemic of lesser magnitude occurred in 1959 in the southern region of Sudan,
with 114 cases and a 77% case fatality rate identified in the area, despite the high vaccine coverage
(70%) [27]. A survey in 1973 confirmed the active circulation of YFV in the area and indicated a high
prevalence of prior exposure (95%) among the nonvaccinated population of central Sudan [28]. YFV
was detected in the Northern Province of Sudan in 1989 with high infection rates (39%) during an
epidemic of febrile illness following heavy rainfall and flooding [6]. Other outbreaks took place in
southern and western Sudan in 2005 and 2012–13, respectively. The low vaccine coverage prior to
the 2005 outbreak and heavy rain were associated with the re-emergence of YF in western Sudan [29].
The 2012 epidemic, considered the worst in Africa in almost quarter of a century (1992–2016, only
superseded by the Angola epidemic in 2016) with more than 800 confirmed cases and about 200
related deaths, primarily affected refugees living in camps. Case fatality rates ranged between 20%
and 32% [29–35]. Unfortunately, the lack of a local arbovirology reference laboratory not only delayed
the official confirmation of the outbreak but left the epidemic to grow exponentially with the local
community unaware of the public health risk. Further, it allowed the virus to spill over into the
neighboring country of Chad [32].
2.1.2. Dengue Virus
Dengue virus (DENV; Flaviviridae) is endemic in Sudan and its distribution was confined to the
coastal and subcoastal regions of the country, where the disease was described for the first time by
Saigh in 1906 and Balfour in 1907 on the Red Sea coast, Port Sudan city [36–39]. Recently, DENV has
been emerging throughout the country (Figure 2). Indeed, most dengue outbreaks in the Middle East
and North Africa were reported from Sudan [40,41]. Sudan was the first country in Africa to report
DENV-1 in 1984; DENV-2 was isolated from patients admitted to a hospital in East Sudan in 1984, and
reported from Kassala state for the first time during an outbreak in 2016/17 [42,43]. DENV infections
were reported from the population of east, north, south, and central Sudan with infection rates ranging
between 7–25%, and these infections were associated with epidemics of febrile illness, following heavy
rain and flooding [5,6,35]. Studies of DENV infection among pregnant women in East Sudan showed
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that they commonly develop severe forms of disease leading to poor maternal and perinatal outcomes,
including 22% maternal death, 24% low birth weight, and 18% preterm delivery [3,44,45]. In 2012,
a relatively high prevalence of dengue and measles co-infection (17%) in addition to 20% and 12%
independent measles and dengue infections, respectively, have placed a great diagnostic challenge
on the resource-limited health system. All of these infections were initially diagnosed as measles,
indicating the diagnostic challenge in endemic areas of east Sudan [46]. An epidemic of dengue
hemorrhagic fever (DHF) with 312 cases occurred among children under 15 years of age, and about 12%
of them manifested with dengue shock syndrome (DSS). DENV-3 was isolated from patients during
the outbreaks, and a 4% case fatality rate was reported in Port Sudan city, East Sudan in 2005 [47].
Outbreaks of dengue fever occurred frequently in the coastal and subcoastal areas of the country.
Another major epidemic caused by DENV-3 occurred in 2010 with incidence up to 72%. About two
thirds of cases presented with DHF and DSS, and more than 4000 cases were detected [41,48–50].
Entomological surveillance showed that Aedes aegypti, notorious as the major vector of this virus in
urban areas, was the predominant mosquito species in the area. Later, in 2015, a novel outbreak of
dengue fever occurred among refugees in the Darfur area, west Sudan, in which DENV-2 and 3 were
co-circulating in the area [51]. This was followed by further outbreak in 2016/17 in east Sudan caused by
DENV-2 [42]. Additionally, studies reported a high prevalence (67%) of DENV infections in Sudan and
up to 89% in the coastal area. They highlighted that most people in these areas were infected repeatedly,
and reported that all DENV (1–4) serotypes are circulating in the area [52,53]. Recently, DENV-1 and
3 emerged and caused an outbreak of dengue fever in the Darfur area, western Sudan [54]. DENV
transmission in Sudan is heterogeneous in space and time, and the major risk factors for infection were
poverty, lack of mosquito control, sleeping outdoors, lack of basic public services such as water supply,
storing drinking water, and geographical location [41,53].Viruses 2020, 12, x FOR PEER REVIEW 3 of 17 
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2.1.3. West Nile Virus
West Nile virus (WNV, Flaviviridae) is endemic in Sudan with infections reported in different
regions of the country since 1942 and 1953–1954 (Figure 3) [6,35,55,56]. Salim and Porterfield suggested
that WNV circulates enzootically in central Sudan, and this was confirmed in 1981 by Omer et al. [28,57].
Country-wide epidemics of WNV infection were reported in 1994, 1996, and 1999, with infection rates
up to 59%, associated with heavy rainfall and flooding [5,6,58]. An outbreak of WNV infection in
2002, southern Sudan, was accompanied by severe neurological manifestations and the development
of encephalitis among 31 children under 12 years of age [59]. WNV infections have been recently
identified in Darfur region, West Sudan in 2015 [54]. There is a significant gap in knowledge about
the epidemiology and risk factors associated with WNV infection, and local vectors have never
been investigated.
2.1.4. Zika Virus
The first evidence of Zika virus (ZIKV; Flaviviridae) circulation in Sudan was reported in 1981
from El Gezira state, central Sudan [57]. A recent study reported a high rate of exposure to ZIKV with
62.7% of 845 blood samples collected from all regions of the country seropositive by ELISA (although
only one was positive by the more specific neutralization test) [60]. Considering the recent association
of ZIKV infection in pregnant women with congenital defects in their infants, and the wide distribution
of ZIKV in Sudan (present in seven of 18 states of the country (Figure 4)), studying ZIKV and it is
epidemiology in Sudan is remarkably limited.
Viruses 2020, 12, 81 5 of 16
Viruses 2020, 12, x FOR PEER REVIEW 5 of 17 
 
 
Figure 3. Map of Sudan showing the prevalence of West Nile virus infections (Green). 
2.1.4. Zika Virus 
The first evidence of Zika virus (ZIKV; Flaviviridae) circulation in Sudan was reported in 1981 
from El Gezira state, central Sudan [57]. A recent study reported a high rate of exposure to ZIKV with 
62.7% of 845 blood samples collected from all regions of the country seropositive by ELISA (although 
only one was positive by the more specific neutralization test) [60]. Considering the recent association 
of ZIKV infection in pregnant women with congenital defects in their infants, and the wide 
distribution of ZIKV in Sudan (present in seven of 18 states of the country (Figure 4)), studying ZIKV 
and it is epidemiology in Sudan is remarkably limited. 
 
f i ).
Viruses 2020, 12, x FOR PEER REVIEW 5 of 17 
 
 
Figure 3. Map of Sudan showing the prevalence of West Nile virus infections (Green). 
2.1.4. Zika Virus 
The first evidence of Zika virus (ZIKV; Flaviviridae) circulation in Sudan was reported in 1981 
from El Gezira state, central Sudan [57]. A recent study reported a high rate of exposure to ZIKV with 
62.7% of 845 blood samples collected from all regions of the country seropositive by ELISA (although 
only one was positive by the more specific neutralization test) [60]. Considering the recent association 
of ZIKV infection in pregnant women with congenital defects in their infants, and the wide 
distribution of ZIKV in Sudan (present in seven of 18 states of the country (Figure 4)), studying ZIKV 
and it is epidemiology in Sudan is remarkably limited. 
 
Figure 4. Map of Sudan showing the prevalence of Zika virus infections (Grey).
2.1.5. Chikungunya Virus
Chikungunya virus (CHIKV; Togaviridae) is endemic with frequent upsurges in Sudan [5,6,28,35,61]
and infections documented in seven of the 18 Sudanese states (Figure 5). The first report of the
disease in Sudan in 1973 showed that the seroprevalence of CHIKV infection in Central Sudan was
13% [28]. Similar seroprevalences were documented in the central and northern provinces of Sudan,
with 10% and 12%, respectively [5,6]. However, studies conducted in the western region of the country
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documented much higher CHIKV seroprevalence, up to 44% [29,35]. An epidemiological survey in
East Sudan using quantitative reverse transcription polymerase chain reaction (qRT-PCR) showed
that 24% of pregnant women were infected with CHIKV and the infections were associated with
preterm delivery [44]. A wider study across the country reported a relatively low seroprevalence of
CHIKV in East and Central Sudan (1.8%) with 100% dengue virus seropositivity [61]. A large-scale
outbreak of chikungunya was ongoing in East Sudan between May 2018 and March 2019, with more
than 47,000 laboratory-confirmed cases [62,63]. Understandably, during epidemics of febrile illnesses,
it is challenging to distinguish arboviral diseases from malaria and other infections due to the lack
of laboratory capacity for proper diagnostics [5,6]. Despite the frequent reports of chikungunya
from different parts of Sudan, there were no entomological studies investigating the vectors of the
disease [61].
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2.1.6. O’nyong-Nyong Virus
The circulation of the only established Anopheles-mosquito-borne human arboviral pathogen,
o’nyong-nyong virus (ONNV), has been reported in Central Sudan with seroprevalence of 13% among
the population of Sennar State [28]. Previous studies suggested a major epidemic, with 2 million
human infections, occurred in East African countries, including Sudan, between 1959 and 1962 [64,65].
Unfortunately, there are no recent studies providing up-to-date information about the epidemiology
and the associated risk factors for ONNV in Sudan.
2.1.7. Rift Valley Fever Virus
Rift Valley fever virus (RVFV; Phenuiviridae) is endemic with frequent outbreaks in Sudan,
mainly in the central region and rich Savannah area, with continuous active transmission in both
humans and animals [5,6,66,67]. RVFV infections have been reported in 50% (9/18) of Sudanese States
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(Figure 6). RVFV was first detected in central Sudan in the 1930 s, then reported from southern
Sudan in 1959 [55,68]. Several epizootics and epidemics took place in 1973, 1976–7, 1984, 2001, 2007–8,
2010, and 2016 [67,69–72]. It is hypothesized that RVFV has been introduced into Egypt from Sudan
through animal exportation [73]. The circulation of RVFV was reported in central and northern
Sudan [5,6,74]. Two major outbreaks occurred in Sudan in 2007 and 2010. In 2007, the outbreak
was most devastating, with more than 700 confirmed human cases and a case fatality rate of 30.8%;
estimated infections were up to 75,000, resulting in a great economic loss due to banning of livestock
trade. Direct contact with infected animals and the use of unpasteurized or uncooked animal products
were major risk factors [66,75–80]. RVFV infection was strongly associated with developing renal
disease, with renal impairment reported from 60% of the 194 RVF patients admitted to Wad Medani
Teaching hospital in 2007 [81]. The limited phylogenetic investigations carried out in the 2007 and
2010 epidemics suggested multiple introductions into Sudan. All of the introduced strains clustered
in the Kenya 1 and 2 sublineages, with the possible presence of other lineages or additional virus
introduction events [76]. A case of vertical RVFV transmission was reported from the Khartoum
teaching hospital [82]. Furthermore, miscarriage in humans was strongly associated with RVF [44].
RVFV was detected in larval and adult stages of several species of mosquitoes (Ae. aegypti, Ae. vittatus,
Ae. vexans, Anopheles arabiensis, An. coustani, and Culex quinquefasciatus) during an outbreak of RVFV in
Sudan, suggesting vertical transmission, but the relative importance of each species in transmission
was not determined [83,84]. A serological survey showed that the circulation of RVFV persists among
the animal populations of Khartoum [69]. Human risk factors associated with RVF include close
contact with infected animals, and consumption of products from sick animals, heavy rainfall, and the
type of soil and land topography [66,75,79,85]. Unfortunately, most animal breeders do not report
suspected infections to the veterinary or health authority to avoid the culling of their herds without
compensation as a control measure for epizootics [86].Viruses 2020, 12, x FOR PEER REVIEW 8 of 17 
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2.2. Tick-Borne Viral Diseases
Crimean-Congo hemorrhagic fever virus (CCHFV; Nairoviridae) is endemic in Sudan,
and infections have been documented throughout the middle region of the country (Figure 7).
The seroprevalence of CCHF in the northern province was 5% in 1989 [6]. Two outbreaks of CCHFV
infection occurred in central and southern Sudan in 2008 and 2009 with a 57% case fatality rate.
Interestingly, despite the short interval between the two epidemics, they were caused by two different
strains of CCHFV, the Mauritanian ArD39554, and one strain belonging to the Group III lineage (strains
commonly found across several African countries) [13,87]. Two nosocomial outbreaks were reported
among healthcare providers who were attending to CCHF patients in endemic areas in southwestern
and central Sudan in 2008 and 2010 [13,88]. The circulation of CCHFV in southwestern and central
Sudan has been reported in cattle populations in 2013 and 2015, with a concomitant outbreak of CCHF
in the human population in 2013 and 2014 [89–91]. CCHFV was detected in various Sudanese domestic
animals from different areas of the country, showing that there is active transmission of the CCHFV in
most of Sudan, with seroprevalence between 7% and 21% [89,91,92]. Tick infestation, age, area, and
animal breeding were risk factors for CCHFV infection among animals. Further, animals following
an open grazing system were 27 times more likely to become infected [89,91,92]. CCHFV has been
isolated from pools of tick including several species removed from Sudanese sheep exported to Saudi
Arabia, but local vectors of CCHFV have not been investigated comprehensively [93]. Detection of
CCHFV in ticks infesting sheep imported from Sudan to Saudi Arabia suggested that the diseases
might have been introduced from Sudan [94].
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2.3. Sandfly-Borne Viral Diseases
Arumowot virus (AMTV; Bu yaviridae) is a sandfly (Phlebotomus)- rne viru first isolated from
a mosquito, Culex antennatus, from Sudan in 1963 [95]. Several sandfly-borne viruses including Sandfly
Fever Sicilian (SFSV) (13–16% seroprevalence), Sandfly Fever Naples (SFNV) (14–33%), Arumowot
(1.4–16.7%), SudAn. 754–61 (17–28%), and Karimabad viruses (1–4%) have been detected in sera
collected in 1 7 from differe t parts of Sudan [96,97]. In 1988, the seroprevalence of SFSV and SFNV in
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central Sudan was 54% and 34%, respectively, and 53% and 32% in northern Sudan in 1989 [5,6]. These
high infection rates of SFS and SFN were detected during epidemics of febrile illness following heavy
rains and flooding [5,6]. Further studies about the burden of these viruses and their distributions are
urgently needed.
3. Risks and Challenges
The burden of arboviral diseases has devastating socioeconomic and health impacts by causing the
loss of human and domesticated animals, and reductions in economic production in endemic countries,
including Sudan [4]. Unfortunately, the risk, distribution, and global burden of arboviruses is increasing
and is predicted to worsen in the future unless serious actions are taken [2]. Nevertheless, a great
challenge during epidemics of arboviral diseases in Sudan is the misclassification and misdiagnosis
during the acute phase due to the similarity in signs and symptoms between arboviral diseases and
several locally circulating infectious diseases, including measles, malaria, and hepatitis, particularly
when the infections are severe [3,5,30,33]. This challenge is not restricted to Sudan, and is a common in
other resource-limited countries [33]. Additionally, the lack of well-established public health policies or
programs for the prevention and control of arboviral diseases in Sudan leaves the local population and
international visitors at greater risk of epidemics and potentially, exportation to new areas. Moreover,
this risk is influenced by the delay and/or lack of sharing the data and information of epidemics and
health emergencies by the health authorities [98]. In addition, there is an obvious weakness in this area
of research due to the limited funds, which are mostly directed toward malaria in malaria-endemic
countries [1,5]. There is a great need for strengthening the surveillance system and raising awareness
of the health policymakers and healthcare providers about the risk of arboviruses, as emphasized in the
World Health Organization’s Global Vector Control Response 2017–2030 [99]. Apparently, as arboviral
infections are greatly under-reported or misdiagnosed, this masks the magnitude of the problem from
the policymakers and leaves the issue worsening. Furthermore, previous local studies failed to identify
the risk factors associated with arboviral infections and epidemics, and such information is crucial for
developing strategic prevention and control plans [60,61].
The major challenge for the prevention, control, and research of arboviruses in Sudan is the
limited diagnostic capacity. The Ministry of Health is relying on external laboratories for confirmation
of arboviral infections, commonly in Germany or Senegal (Figure 8) [30,31,34], resulting in delays in
responses. The lack of advanced diagnostics with high sensitivity creates a great diagnostic challenge for
the surveillance system and limits early detection of diseases [3]. This technological gap, in turn, creates
a significant limitation in our knowledge, and many unanswered questions about the epidemiology
and dynamics of these diseases and their vectors remain. Such information is crucial for developing
an effective prevention and control strategy [100–105]. In addition to saving many lives, utilizing
recent advancements in the biomedical research could help in elucidating the molecular epidemiology,
dynamics, and evolution of arboviral diseases, improving our understanding about the transmission of
these viruses and reshaping our prevention, control, and containment strategies (Figure 8) [7,12]. There
is also a need to develop multisectoral programs for controlling many of these arboviral diseases. This
is critically important in Sudan’s towns and cities, where populations of the world’s most important
vector of arboviral diseases, Ae. aegypti, are likely to thrive. Genetic and behavioral characterizations
of Ae. aegypti populations to determine which represent peridomestic (Ae. aegypti aegypti) versus
sylvatic (Ae. aegypti formosus) populations are also needed. In urban areas in particular, trash removal,
the provision of reliable piped water, house screening, and infrastructure that does not provide aquatic
habitats for this vector is essential for reducing the threat from diseases like chikungunya, dengue,
Zika, and yellow fever. As Sudan’s towns and cities continue to grow, there has never been a better
time to do this [106].
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4. Conclusions and Recommendations
Although the risk of arboviral diseases in Sudan is high, it receives little attention, mainly due
to limited resources, which heavily undermines building the capacity of healthcare providers and
researchers with advanced training. Also, the lack of advanced diagnostic tools is a major challenge
as detection of arboviruses typically requires molecular techniques and equipment such as simple
polymerase chain reaction (PCR) machines that are available in very limited healthcare facilities.
Additionally, the very inadequate funding for research limits the generation of evidence about the
epidemiology and dynamics of arboviruses in Sudan; therefore, neither healthcare providers nor
health policymakers are aware of these remarkably fast-growing public health threats and the need
to develop a multisectoral approach to disease control and prevention. It is critically important to
improve surveillance and investigate the circulating strains of these viruses and to establish viral
genomic databases as a reference for current and future research. An arbovirology research center
in Sudan, which would offer an extraordinary opportunity to advance the research and control of
arboviral diseases in the region, is critically needed (Figure 8). This could occur through local and
international partnerships to generate evidence about the burden of disease, building the capacity of
the local scientists, healthcare providers, and public health policymakers, and raising the awareness of
the public and related stakeholders about the risk and need for prevention and control interventions.
Drawing global attention to fill gaps in funding, research, and healthcare particularly for the poor and
remote communities would likely save many lives and avoid great economic loss.
We highlight the urgent need for raising awareness among healthcare providers, researchers,
and policymakers about the issue of arboviral infections, building the capacity of Sudan biomedical
laboratories, and increasing the funding for research, particularly to investigate the burden of infectious
diseases. Also, improving surveillance, diagnostics, and strengthening the health system overall
by adopting a multisectoral approach to control will help in detecting the early emergence of these
infections to take action to mediate massive epidemics. Particular attention needs to be paid to
reducing the threat of arboviral diseases in the most vulnerable groups in the community, including
people living in humanitarian crisis settings, informal settlements, refugees and nomads, and generally,
impoverished people throughout Sudan.
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